Canadian Healthcare Technology published a TVB Associates’ study for the University of Windsor on the business case for medical isotope production to support the local PET scanner.
Our study examined the challenge of equitable access to PET scans as a pricing problem. Viability of PET scanning is typically only available in cities large enough to sustain a local radiopharmaceutical manufacturer that produces F-18 and converts it into the radiopharmaceutical needed for PET scanning, known as FDG. We considered business and pricing models that could sustain a PET scanner and an FDG production business in Windsor, Ontario, a small Canadian city.
Our main results are reported in a white paper and a summary article, both published through Canadian Healthcare Technology.
- Summary: Daniel Banks and Drew Marquardt. Sustainability of F18 medical isotope production in small Canadian cities: Canadian Healthcare Technology. June/July 2023. Vol. 28(5): 19.
- White Paper: Daniel Banks, Joe Huser, Dale Schick-Martin, Drew Marquardt. Sustainability of F18 medical isotope production in small Canadian cities. University of Windsor. Distributed through Canadian Healthcare Technology White Papers. June 28, 2023. Volume 13, Number 6.